Sanofi Genzyme has announced the Rare Genomics Institute as one of winners of the 2016 Patient Advocacy Leadership (PAL) Awards. The PAL Awards support projects by non-profit organizations that serve patients living with lysosomal storage disorders (LSDs), a group of rare diseases.
The Rare Genomics Institute, working together with the Organization for Rare Disease India, submitted a winning proposal for creating training modules and other educational materials on genomic sequencing for patients, caregivers, patient advocates, and physicians. Because the genes for many LSDs have been identified, genomic sequencing is a useful tool in for diagnosis. However, a lack of education presents a barrier to this resource. The Rare Genomics Institute and the Organization for Rare Disease India hope to mitigate this barrier through improved education.
Read more about the 2016 PAL Awards at Sanofi Genzyme.